When these medications are for chronic conditions, such as high cholesterol and diabetes the non-adherence can lead to worsening health conditions and hospitalizations
Dr Samuel Cross of Imperial College London, one of the study's authors, noted that obesity and diabetes are chronic diseases that increase the risk of stroke, diabetes, heart disease, kidney failure, and cancer
Enhancing bone density Some studies suggest IGF-1 can strengthen bone structure, reducing injury risks
Yes tirzepatide (branded as Zepbound) is FDA-approved as of December 2024 for obstructive sleep apnea in adults with obesity, based on the SURMOUNT-OSA trial showing reductions in apnea-hypopnea index alongside weight reduction
It is an odd but more deliberate kind of cancer in comparison to NMSC